売上原価、剰余金の配当、のれん償却額 - ドラッグ・ファーマシー
- 【期間】
| 年度 | 売上原価 | 剰余金の配当 | のれん償却額 - ドラッグ・ファーマシー |
|---|
| 2009/02 | 3.37兆 | | -130億 | | - | |
| 2010/02 | 3.27兆 | -3.1% | -130億 | ±0% | - | |
| 2011/02 | 3.32兆 | +1.6% | -153億 | 赤拡 | - | |
| 2012/02 | 3.39兆 | +2.1% | -161億 | 赤拡 | - | |
| 2013/02 | 3.7兆 | +8.9% | -272億 | 赤拡 | - | |
| 2014/02 | 4.1兆 | +11% | - | | - | |
| 2015/02 | 4.53兆 | +10.3% | - | | 8.07億 | |
| 2016/02 | 5.27兆 | +16.4% | - | | 30.7億 | +279.8% |
| 2017/02 | 5.25兆 | -0.4% | - | | 39.9億 | +30.3% |
| 2018/02 | 5.33兆 | +1.5% | - | | 34.6億 | -13.4% |
| 2019/02 | 5.39兆 | +1.3% | - | | - | |
| 2020/02 | 5.43兆 | +0.7% | - | | - | |
| 2021/02 | 5.51兆 | +1.4% | - | | - | |
| 2022/02 | 5.54兆 | +0.6% | - | | - | |
| 2023/02 | 5.73兆 | +3.4% | - | | - | |
| 2024/02 | 5.95兆 | +4% | - | | - | |
